Mereo BioPharma Group plc Cash Flow Quality Index
Mereo BioPharma Group plc cash flow quality index. Mereo BioPharma Group plc (MAH0) has a Cash Flow Quality Index of -23.77x as of December 2021. Operating cash flow of €-7.57 Million is below net income of €318.50K, suggesting accrual-heavy earnings not yet converted to cash. See MAH0 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Mereo BioPharma Group plc (2021–2021)
Cash flow quality index of Mereo BioPharma Group plc from 2021 to 2021. Historical Cash Flow Quality Index for Mereo BioPharma Group plc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore MAH0 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Mereo BioPharma Group plc Cash Flow Quality Index by Year (2021–2021)
Mereo BioPharma Group plc cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Mereo BioPharma Group plc. For the full cash flow conversion analysis, see how efficiently does Mereo BioPharma Group plc generate cash.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.41x | €-5.24 Million | €12.72 Million | — |